T. Rowe Price Associates’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $560K | Buy |
|
|||||
|
2025
Q2 | $675K | Buy |
|
|||||
|
2025
Q1 | $523K | Buy |
|
|||||
|
2024
Q4 | $581K | Buy |
|
|||||
|
2024
Q3 | $753K | Sell |
|
|||||
|
2024
Q2 | $468K | Buy |
|
|||||
|
2024
Q1 | $312K | Buy |
|
|||||
|
2023
Q4 | $325K | Sell |
|
|||||
|
2023
Q3 | $301K | Buy |
|
|||||
|
2023
Q2 | $308K | Buy |
|
|||||
|
2023
Q1 | $289K | Sell |
|
|||||
|
2022
Q4 | $3.06M | Sell |
|
|||||
|
2022
Q3 | $6.94M | Sell |
|
|||||
|
2022
Q2 | $8.77M | Sell |
|
|||||
|
2022
Q1 | $27.1M | Sell |
|
|||||
|
2021
Q4 | $38.6M | Buy |
|
|||||
|
2021
Q3 | $48.9M | Sell |
|
|||||
|
2021
Q2 | $71.4M | Sell |
|
|||||
|
2021
Q1 | $54.7M | Sell |
|
|||||
|
2020
Q4 | $103M | Buy |
|
|||||
|
2020
Q3 | $51.3M | Sell |
|
|||||
|
2020
Q2 | $65M | Buy |
|
|||||
|
2020
Q1 | $3.05M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $3.64M | Sell |
|
|||||
|
2019
Q2 | $16.8M | Buy |
|
|||||
|
2019
Q1 | $12.8M | Buy |
|
|||||
|
2018
Q4 | $8.06M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $107K | Sell |
|
|||||
|
2015
Q1 | $154K | Buy |
|